FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020102114> ?p ?o ?g. }

• W2020102114 abstract "In Canada, public drug plans provide limited reimbursement for Alzheimer's disease (AD) medications. For most Canadians, the cost of these medications is paid ‘out-of-pocket-’. This study was conducted to assess the Canadian general public's willingness-to-pay (WTP) for unrestricted access to AD medications. Five-hundred participants (age 18 years or older) were recruited nationally and stratified by income. Data were collected via computer-assisted telephone interviews. Participants were presented with four ‘efficacy’ scenarios describing a hypothetical, new AD medication. In two scenarios, the medication was described as modifying the symptoms of cognitive decline. In the other two scenarios, the medication was described as halting disease progression. For each pair of ‘efficacy’ scenarios, the medication was assumed to have no adverse effects in one scenario and a 30% chance of adverse effects in the other scenario. For every scenario, participants were asked whether they would support unrestricted access to the medication through an annual increase in personal income taxes. Participants who responded affirmatively were asked to provide the maximum tax increase that they would support (maximum WTP). WTP was elicited using a bid range: $75, $150, or $225. Open-ended questions allowed participants to specify values outside the range. Participants were randomized to order of scenarios and bids. Differences between scenarios were assessed using Bowker's test of symmetry. Participants' median age was 51 years (interquartile range = 40 to 64 years) and 61% (n = 305) were female. Overall, 80% of participants (n = 398) supported a tax increase under at least one scenario. Maximum WTP did not differ across scenarios (median = $150, interquartile range = $75 to $225 [for all four scenarios]). After categorization (less than $75, $75, $150, $225, greater than $225), the distribution of maximum WTP did not differ by efficacy (symptom modification versus halting disease progression [p > 0.34]) or adverse effects (30% chance versus none [p > 0.54]). Most participants reported support for a tax increase. Once the decision was made to support an increase, maximum WTP was unaffected by efficacy or the potential for adverse effects." @default.
• W2020102114 created "2016-06-24" @default.
• W2020102114 creator A5006693469 @default.
• W2020102114 creator A5011503676 @default.
• W2020102114 creator A5044465379 @default.
• W2020102114 creator A5049220408 @default.
• W2020102114 date "2009-07-01" @default.
• W2020102114 modified "2023-10-18" @default.
• W2020102114 title "P1-222: Canadians’ willingness to pay for Alzheimer's disease medications: Preliminary results of a study of the general public" @default.
• W2020102114 doi "https://doi.org/10.1016/j.jalz.2009.04.229" @default.
• W2020102114 hasPublicationYear "2009" @default.
• W2020102114 type Work @default.
• W2020102114 sameAs 2020102114 @default.
• W2020102114 citedByCount "0" @default.
• W2020102114 crossrefType "journal-article" @default.
• W2020102114 hasAuthorship W2020102114A5006693469 @default.
• W2020102114 hasAuthorship W2020102114A5011503676 @default.
• W2020102114 hasAuthorship W2020102114A5044465379 @default.
• W2020102114 hasAuthorship W2020102114A5049220408 @default.
• W2020102114 hasConcept C119060515 @default.
• W2020102114 hasConcept C126322002 @default.
• W2020102114 hasConcept C144024400 @default.
• W2020102114 hasConcept C149923435 @default.
• W2020102114 hasConcept C15744967 @default.
• W2020102114 hasConcept C160735492 @default.
• W2020102114 hasConcept C162324750 @default.
• W2020102114 hasConcept C175444787 @default.
• W2020102114 hasConcept C197934379 @default.
• W2020102114 hasConcept C2777364431 @default.
• W2020102114 hasConcept C2778834376 @default.
• W2020102114 hasConcept C2779134260 @default.
• W2020102114 hasConcept C2779703844 @default.
• W2020102114 hasConcept C36289849 @default.
• W2020102114 hasConcept C50522688 @default.
• W2020102114 hasConcept C512399662 @default.
• W2020102114 hasConcept C71924100 @default.
• W2020102114 hasConcept C74909509 @default.
• W2020102114 hasConceptScore W2020102114C119060515 @default.
• W2020102114 hasConceptScore W2020102114C126322002 @default.
• W2020102114 hasConceptScore W2020102114C144024400 @default.
• W2020102114 hasConceptScore W2020102114C149923435 @default.
• W2020102114 hasConceptScore W2020102114C15744967 @default.
• W2020102114 hasConceptScore W2020102114C160735492 @default.
• W2020102114 hasConceptScore W2020102114C162324750 @default.
• W2020102114 hasConceptScore W2020102114C175444787 @default.
• W2020102114 hasConceptScore W2020102114C197934379 @default.
• W2020102114 hasConceptScore W2020102114C2777364431 @default.
• W2020102114 hasConceptScore W2020102114C2778834376 @default.
• W2020102114 hasConceptScore W2020102114C2779134260 @default.
• W2020102114 hasConceptScore W2020102114C2779703844 @default.
• W2020102114 hasConceptScore W2020102114C36289849 @default.
• W2020102114 hasConceptScore W2020102114C50522688 @default.
• W2020102114 hasConceptScore W2020102114C512399662 @default.
• W2020102114 hasConceptScore W2020102114C71924100 @default.
• W2020102114 hasConceptScore W2020102114C74909509 @default.
• W2020102114 hasIssue "4S_Part_8" @default.
• W2020102114 hasLocation W20201021141 @default.
• W2020102114 hasOpenAccess W2020102114 @default.
• W2020102114 hasPrimaryLocation W20201021141 @default.
• W2020102114 hasRelatedWork W2061253854 @default.
• W2020102114 hasRelatedWork W2176608732 @default.
• W2020102114 hasRelatedWork W2748952813 @default.
• W2020102114 hasRelatedWork W2899084033 @default.
• W2020102114 hasRelatedWork W2971392718 @default.
• W2020102114 hasRelatedWork W3037686638 @default.
• W2020102114 hasRelatedWork W3157932611 @default.
• W2020102114 hasRelatedWork W3162511055 @default.
• W2020102114 hasRelatedWork W3196792450 @default.
• W2020102114 hasRelatedWork W4311498144 @default.
• W2020102114 hasVolume "5" @default.
• W2020102114 isParatext "false" @default.
• W2020102114 isRetracted "false" @default.
• W2020102114 magId "2020102114" @default.
• W2020102114 workType "article" @default.